The primary perform of these transporters should be to terminate monoamine transmission by reuptake from the released neurotransmitters. Interaction of psychoactive medicine with the monoamine transporters inhibits this reuptake leading to an increase in the concentration of dopamine, norepinephrine and serotonin in the synaptic cleft.[nine][one] T